Mutual Fund Details

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Equity Pharma

NAV

₹32.4100

as on 22 Apr 2024, 11:15 PM

₹0.3100(0.97%)

Last Change

Scheme Ratings

Pharma

5Y Returns

Pharma

Rankings based on 5Y Returns | as on 23 Apr 2024

DSP Healthcare Fund Direct - Growth

27.13%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

25.64%

Mirae Asset Healthcare Fund Direct - Growth

25.51%

SBI Healthcare Opportunities Fund Direct Plan-Growth

23.98%

Tata India Pharma & HealthCare Fund Direct-Growth

23.93%

Schemes Managed By

Dharmesh Kakkad

Fund Manager

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,62,014

₹1,66,461

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹66,461

Profit (absolute return)

66.46%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

7.96%

In the last 6 months

27.05%

In the last 1 year

58.01%

In the last 3 years

66.46%

In the last 5 years

213.44%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

as of 31 Mar 2024, 05:30 AM

₹3,772.32 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 15 days.

1.05%

Expense Ratio

Plan

Growth

5.76%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 15 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

88.79%

₹3,349.42 Cr

Chemicals

4.84%

₹182.76 Cr

Insurance

4.38%

₹165.17 Cr

Services

0.69%

₹26.07 Cr

Others

1.30%

₹49.04 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

88.79%

₹3,349.42 Cr

Chemicals

4.84%

₹182.76 Cr

Insurance

4.38%

₹165.17 Cr

Services

0.69%

₹26.07 Cr

Others

1.30%

₹49.04 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.24%

₹574.90 Cr

Dr. Reddy's Laboratories Ltd.

7.19%

₹271.23 Cr

Divi's Laboratories Ltd.

6.68%

₹251.99 Cr

Aurobindo Pharma Ltd.

6.56%

₹247.46 Cr

Apollo Hospitals Enterprise Ltd.

6.45%

₹243.31 Cr

Others

57.88%

₹2,183.42 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.24%

₹574.90 Cr

Dr. Reddy's Laboratories Ltd.

7.19%

₹271.23 Cr

Divi's Laboratories Ltd.

6.68%

₹251.99 Cr

Aurobindo Pharma Ltd.

6.56%

₹247.46 Cr

Apollo Hospitals Enterprise Ltd.

6.45%

₹243.31 Cr

Others

57.88%

₹2,183.42 Cr

View All

Funds in this Category

This fund's returns:

18.50%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

DSP Healthcare Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Dharmesh Kakkad. It has an AUM of ₹3,772.32 Crores and the latest NAV decalared is ₹32.410 as on 23 Apr 2024 at 10:32 pm.

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth scheme return performance in last 1 year is 58.01%, in last 3 years is 66.46% and 227.37% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.